APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Poliovirus Vaccine Inactivated

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Poliovirus Vaccine Inactivated Industry Growth and Trends Forecast to 2032

Report ID 174026920122 December 202579 pages

Choose your research edition.

Industry ResearchPoliovirus Vaccine Inactivated Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Poliovirus Vaccine Inactivated Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Poliovirus Vaccine Inactivated Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Poliovirus Vaccine Inactivated Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Poliovirus Vaccine Inactivated Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Poliovirus Vaccine Inactivated market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Poliovirus Vaccine Inactivated is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Poliovirus Vaccine Inactivated is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Poliovirus Vaccine Inactivated is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Poliovirus Vaccine Inactivated include IMBCA, Serum Institute (Bilthoven Biologicals), GSK and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Poliovirus Vaccine Inactivated market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Poliovirus Vaccine Inactivated market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Poliovirus Vaccine Inactivated market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Poliovirus Vaccine Inactivated.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Poliovirus Vaccine Inactivated market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Poliovirus Vaccine Inactivated Market by Company

IMBCA

Serum Institute (Bilthoven Biologicals)

GSK

Sanofi

Poliovirus Vaccine Inactivated Segment by Type

Human Diploid Cell

Monkey Kidney Cell

Poliovirus Vaccine Inactivated Segment by Application

Public

Private

Poliovirus Vaccine Inactivated Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poliovirus Vaccine Inactivated market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poliovirus Vaccine Inactivated and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poliovirus Vaccine Inactivated.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Poliovirus Vaccine Inactivated manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Poliovirus Vaccine Inactivated in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Human Diploid Cell Table 2. Major Company of Monkey Kidney Cell Table 3. Global Poliovirus Vaccine Inactivated Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (k units) Table 5. Global Poliovirus Vaccine Inactivated Sales Market Share in Volume by Type (2021-2026) Table 6. Global Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (US$ Million) Table 7. Global Poliovirus Vaccine Inactivated Sales Market Share in Value by Type (2021-2026) Table 8. Global Poliovirus Vaccine Inactivated Price by Type (2021-2026) & (US$/unit) Table 9. Global Poliovirus Vaccine Inactivated Sales by Type (2027-2032) & (k units) Table 10. Global Poliovirus Vaccine Inactivated Sales Market Share in Volume by Type (2027-2032) Table 11. Global Poliovirus Vaccine Inactivated Sales by Type (2027-2032) & (US$ Million) Table 12. Global Poliovirus Vaccine Inactivated Sales Market Share in Value by Type (2027-2032) Table 13. Global Poliovirus Vaccine Inactivated Price by Type (2027-2032) & (US$/unit) Table 14. North America Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (k units) Table 15. North America Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (k units) Table 17. Europe Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (k units) Table 21. Latin America Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Poliovirus Vaccine Inactivated Sales by Type (2021-2026) & (US$ Million) Table 24. Poliovirus Vaccine Inactivated Industry Trends Table 25. Poliovirus Vaccine Inactivated Industry Drivers Table 26. Poliovirus Vaccine Inactivated Industry Opportunities and Challenges Table 27. Poliovirus Vaccine Inactivated Industry Restraints Table 28. Global Poliovirus Vaccine Inactivated Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Poliovirus Vaccine Inactivated Revenue Market Share by Company (2021-2026) Table 30. Global Poliovirus Vaccine Inactivated Sales by Company (2021-2026) & (k units) Table 31. Global Poliovirus Vaccine Inactivated Sales Share by Company (2021-2026) Table 32. Global Poliovirus Vaccine Inactivated Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Poliovirus Vaccine Inactivated Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Poliovirus Vaccine Inactivated Major Company Production Sites and Headquarters Table 35. Global Poliovirus Vaccine Inactivated Company, Product Type & Application Table 36. Global Poliovirus Vaccine Inactivated Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Poliovirus Vaccine Inactivated by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Poliovirus Vaccine Inactivated Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Poliovirus Vaccine Inactivated Sales by Region (2021-2026) & (k units) Table 41. Global Poliovirus Vaccine Inactivated Sales Market Share in Volume by Region (2021-2026) Table 42. Global Poliovirus Vaccine Inactivated Sales by Region (2021-2026) & (US$ Million) Table 43. Global Poliovirus Vaccine Inactivated Sales Market Share in Value by Region (2021-2026) Table 44. Global Poliovirus Vaccine Inactivated Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Poliovirus Vaccine Inactivated Sales by Region (2027-2032) & (k units) Table 46. Global Poliovirus Vaccine Inactivated Sales Market Share in Volume by Region (2027-2032) Table 47. Global Poliovirus Vaccine Inactivated Sales by Region (2027-2032) & (US$ Million) Table 48. Global Poliovirus Vaccine Inactivated Sales Market Share in Value by Region (2027-2032) Table 49. Global Poliovirus Vaccine Inactivated Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Poliovirus Vaccine Inactivated Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (k units) Table 52. Global Poliovirus Vaccine Inactivated Sales Market Share in Volume by Application (2021-2026) Table 53. Global Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (US$ Million) Table 54. Global Poliovirus Vaccine Inactivated Sales Market Share in Value by Application (2021-2026) Table 55. Global Poliovirus Vaccine Inactivated Price by Application (2021-2026) & (US$/unit) Table 56. Global Poliovirus Vaccine Inactivated Sales by Application (2027-2032) & (k units) Table 57. Global Poliovirus Vaccine Inactivated Sales Market Share in Volume by Application (2027-2032) Table 58. Global Poliovirus Vaccine Inactivated Sales by Application (2027-2032) & (US$ Million) Table 59. Global Poliovirus Vaccine Inactivated Sales Market Share in Value by Application (2027-2032) Table 60. Global Poliovirus Vaccine Inactivated Price by Application (2027-2032) & (US$/unit) Table 61. North America Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (k units) Table 62. North America Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (k units) Table 64. Europe Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (k units) Table 68. Latin America Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Poliovirus Vaccine Inactivated Sales by Application (2021-2026) & (US$ Million) Table 71. IMBCA Company Information Table 72. IMBCA Business Overview Table 73. IMBCA Poliovirus Vaccine Inactivated Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. IMBCA Poliovirus Vaccine Inactivated Product Portfolio Table 75. IMBCA Recent Development Table 76. Serum Institute (Bilthoven Biologicals) Company Information Table 77. Serum Institute (Bilthoven Biologicals) Business Overview Table 78. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Portfolio Table 80. Serum Institute (Bilthoven Biologicals) Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Poliovirus Vaccine Inactivated Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. GSK Poliovirus Vaccine Inactivated Product Portfolio Table 85. GSK Recent Development Table 86. Sanofi Company Information Table 87. Sanofi Business Overview Table 88. Sanofi Poliovirus Vaccine Inactivated Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Sanofi Poliovirus Vaccine Inactivated Product Portfolio Table 90. Sanofi Recent Development Table 91. North America Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 92. North America Poliovirus Vaccine Inactivated Sales by Country (2021-2026) & (k units) Table 93. North America Poliovirus Vaccine Inactivated Sales Market Share by Country (2021-2026) Table 94. North America Poliovirus Vaccine Inactivated Sales Forecast by Country (2027-2032) & (k units) Table 95. North America Poliovirus Vaccine Inactivated Sales Market Share Forecast by Country (2027-2032) Table 96. North America Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Poliovirus Vaccine Inactivated Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Poliovirus Vaccine Inactivated Market Share by Country (2021-2026) Table 99. North America Poliovirus Vaccine Inactivated Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Poliovirus Vaccine Inactivated Market Share Forecast by Country (2027-2032) Table 101. Europe Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. Europe Poliovirus Vaccine Inactivated Sales by Country (2021-2026) & (k units) Table 103. Europe Poliovirus Vaccine Inactivated Sales Market Share by Country (2021-2026) Table 104. Europe Poliovirus Vaccine Inactivated Sales Forecast by Country (2027-2032) & (k units) Table 105. Europe Poliovirus Vaccine Inactivated Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Poliovirus Vaccine Inactivated Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Poliovirus Vaccine Inactivated Market Share by Country (2021-2026) Table 109. Europe Poliovirus Vaccine Inactivated Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Poliovirus Vaccine Inactivated Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Poliovirus Vaccine Inactivated Sales by Country (2021-2026) & (k units) Table 113. Asia-Pacific Poliovirus Vaccine Inactivated Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Poliovirus Vaccine Inactivated Sales Forecast by Country (2027-2032) & (k units) Table 115. Asia-Pacific Poliovirus Vaccine Inactivated Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Poliovirus Vaccine Inactivated Market Share by Country (2021-2026) Table 119. Asia-Pacific Poliovirus Vaccine Inactivated Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Poliovirus Vaccine Inactivated Market Share Forecast by Country (2027-2032) Table 121. Latin America Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Latin America Poliovirus Vaccine Inactivated Sales by Country (2021-2026) & (k units) Table 123. Latin America Poliovirus Vaccine Inactivated Sales Market Share by Country (2021-2026) Table 124. Latin America Poliovirus Vaccine Inactivated Sales Forecast by Country (2027-2032) & (k units) Table 125. Latin America Poliovirus Vaccine Inactivated Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Poliovirus Vaccine Inactivated Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Poliovirus Vaccine Inactivated Market Share by Country (2021-2026) Table 129. Latin America Poliovirus Vaccine Inactivated Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Poliovirus Vaccine Inactivated Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Poliovirus Vaccine Inactivated Sales by Country (2021-2026) & (k units) Table 133. Middle East and Africa Poliovirus Vaccine Inactivated Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Poliovirus Vaccine Inactivated Sales Forecast by Country (2027-2032) & (k units) Table 135. Middle East and Africa Poliovirus Vaccine Inactivated Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Poliovirus Vaccine Inactivated Market Share by Country (2021-2026) Table 139. Middle East and Africa Poliovirus Vaccine Inactivated Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Poliovirus Vaccine Inactivated Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Poliovirus Vaccine Inactivated Distributors List Table 144. Poliovirus Vaccine Inactivated Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Poliovirus Vaccine Inactivated Image Figure 2. Global Poliovirus Vaccine Inactivated Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poliovirus Vaccine Inactivated Market Size (2021-2032) & (US$ Million) Figure 4. Global Poliovirus Vaccine Inactivated Sales (2021-2032) & (k units) Figure 5. Human Diploid Cell Image Figure 6. Global Human Diploid Cell Sales YoY Growth (2021-2032) & (k units) Figure 7. Monkey Kidney Cell Image Figure 8. Global Monkey Kidney Cell Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Poliovirus Vaccine Inactivated Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Poliovirus Vaccine Inactivated Market Share by Type 2025 VS 2032 Figure 11. North America Poliovirus Vaccine Inactivated Sales Market Share in Volume by Type in 2025 Figure 12. North America Poliovirus Vaccine Inactivated Sales Market Share in Value by Type in 2025 Figure 13. Europe Poliovirus Vaccine Inactivated Sales Market Share in Volume by Type in 2025 Figure 14. Europe Poliovirus Vaccine Inactivated Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Poliovirus Vaccine Inactivated Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Poliovirus Vaccine Inactivated Sales Market Share in Value by Type in 2025 Figure 17. Latin America Poliovirus Vaccine Inactivated Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Poliovirus Vaccine Inactivated Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Poliovirus Vaccine Inactivated Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Poliovirus Vaccine Inactivated Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Poliovirus Vaccine Inactivated Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Public Image Figure 24. Global Public Sales YoY Growth (2021-2032) & (k units) Figure 25. Private Image Figure 26. Global Private Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Poliovirus Vaccine Inactivated Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Poliovirus Vaccine Inactivated Market Share by Application 2025 VS 2032 Figure 29. North America Poliovirus Vaccine Inactivated Sales Market Share in Volume by Application in 2025 Figure 30. North America Poliovirus Vaccine Inactivated Sales Market Share in Value by Application in 2025 Figure 31. Europe Poliovirus Vaccine Inactivated Sales Market Share in Volume by Application in 2025 Figure 32. Europe Poliovirus Vaccine Inactivated Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Poliovirus Vaccine Inactivated Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Poliovirus Vaccine Inactivated Sales Market Share in Value by Application in 2025 Figure 35. Latin America Poliovirus Vaccine Inactivated Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Poliovirus Vaccine Inactivated Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Poliovirus Vaccine Inactivated Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Poliovirus Vaccine Inactivated Sales Market Share in Value by Application in 2025 Figure 39. North America Poliovirus Vaccine Inactivated Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Poliovirus Vaccine Inactivated Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Poliovirus Vaccine Inactivated Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Poliovirus Vaccine Inactivated Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Poliovirus Vaccine Inactivated Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Poliovirus Vaccine Inactivated Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Poliovirus Vaccine Inactivated Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Poliovirus Vaccine Inactivated Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Poliovirus Vaccine Inactivated Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Poliovirus Vaccine Inactivated Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Poliovirus Vaccine Inactivated Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Poliovirus Vaccine Inactivated Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Poliovirus Vaccine Inactivated Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Poliovirus Vaccine Inactivated Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Poliovirus Vaccine Inactivated Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Poliovirus Vaccine Inactivated Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Poliovirus Vaccine Inactivated Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Poliovirus Vaccine Inactivated Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Poliovirus Vaccine Inactivated Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Poliovirus Vaccine Inactivated Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Human Diploid Cell
  • Monkey Kidney Cell
Applications
  • Public
  • Private
Companies covered
  • IMBCA
  • Serum Institute (Bilthoven Biologicals)
  • GSK
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Poliovirus Vaccine Inactivated Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Poliovirus Vaccine Inactivated Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Poliovirus Vaccine Inactivated Market by Type
  6. 1.3.1 Human Diploid Cell
  7. 1.3.2 Monkey Kidney Cell
  8. 1.4 Global Poliovirus Vaccine Inactivated Market Size by Type
  9. 1.4.1 Global Poliovirus Vaccine Inactivated Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Poliovirus Vaccine Inactivated Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Poliovirus Vaccine Inactivated Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Poliovirus Vaccine Inactivated Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Poliovirus Vaccine Inactivated Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Poliovirus Vaccine Inactivated Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Poliovirus Vaccine Inactivated Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Poliovirus Vaccine Inactivated Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Poliovirus Vaccine Inactivated Industry Trends
  2. 2.2 Poliovirus Vaccine Inactivated Industry Drivers
  3. 2.3 Poliovirus Vaccine Inactivated Industry Opportunities and Challenges
  4. 2.4 Poliovirus Vaccine Inactivated Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Poliovirus Vaccine Inactivated Revenue (2021-2026)
  2. 3.2 Global Top Players by Poliovirus Vaccine Inactivated Sales (2021-2026)
  3. 3.3 Global Top Players by Poliovirus Vaccine Inactivated Price (2021-2026)
  4. 3.4 Global Poliovirus Vaccine Inactivated Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Poliovirus Vaccine Inactivated Major Company Production Sites & Headquarters
  6. 3.6 Global Poliovirus Vaccine Inactivated Company, Product Type & Application
  7. 3.7 Global Poliovirus Vaccine Inactivated Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Poliovirus Vaccine Inactivated Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Poliovirus Vaccine Inactivated Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Poliovirus Vaccine Inactivated Tier 1, Tier 2, and Tier 3
4 Poliovirus Vaccine Inactivated Regional Status and Outlook
  1. 4.1 Global Poliovirus Vaccine Inactivated Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Poliovirus Vaccine Inactivated Historic Market Size by Region
  3. 4.2.1 Global Poliovirus Vaccine Inactivated Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Poliovirus Vaccine Inactivated Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Poliovirus Vaccine Inactivated Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Poliovirus Vaccine Inactivated Forecasted Market Size by Region
  7. 4.3.1 Global Poliovirus Vaccine Inactivated Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Poliovirus Vaccine Inactivated Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Poliovirus Vaccine Inactivated Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Poliovirus Vaccine Inactivated by Application
  1. 5.1 Poliovirus Vaccine Inactivated Market by Application
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Poliovirus Vaccine Inactivated Market Size by Application
  5. 5.2.1 Global Poliovirus Vaccine Inactivated Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Poliovirus Vaccine Inactivated Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Poliovirus Vaccine Inactivated Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Poliovirus Vaccine Inactivated Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Poliovirus Vaccine Inactivated Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Poliovirus Vaccine Inactivated Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Poliovirus Vaccine Inactivated Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Poliovirus Vaccine Inactivated Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 IMBCA
  2. 6.1.1 IMBCA Company Information
  3. 6.1.2 IMBCA Business Overview
  4. 6.1.3 IMBCA Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 IMBCA Poliovirus Vaccine Inactivated Product Portfolio
  6. 6.1.5 IMBCA Recent Developments
  7. 6.2 Serum Institute (Bilthoven Biologicals)
  8. 6.2.1 Serum Institute (Bilthoven Biologicals) Company Information
  9. 6.2.2 Serum Institute (Bilthoven Biologicals) Business Overview
  10. 6.2.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Portfolio
  12. 6.2.5 Serum Institute (Bilthoven Biologicals) Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Poliovirus Vaccine Inactivated Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Poliovirus Vaccine Inactivated Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Poliovirus Vaccine Inactivated Sales by Country
  2. 7.1.1 North America Poliovirus Vaccine Inactivated Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Poliovirus Vaccine Inactivated Sales by Country (2021-2026)
  4. 7.1.3 North America Poliovirus Vaccine Inactivated Sales Forecast by Country (2027-2032)
  5. 7.2 North America Poliovirus Vaccine Inactivated Market Size by Country
  6. 7.2.1 North America Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Poliovirus Vaccine Inactivated Market Size by Country (2021-2026)
  8. 7.2.3 North America Poliovirus Vaccine Inactivated Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Poliovirus Vaccine Inactivated Sales by Country
  2. 8.1.1 Europe Poliovirus Vaccine Inactivated Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Poliovirus Vaccine Inactivated Sales by Country (2021-2026)
  4. 8.1.3 Europe Poliovirus Vaccine Inactivated Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Poliovirus Vaccine Inactivated Market Size by Country
  6. 8.2.1 Europe Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Poliovirus Vaccine Inactivated Market Size by Country (2021-2026)
  8. 8.2.3 Europe Poliovirus Vaccine Inactivated Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Poliovirus Vaccine Inactivated Sales by Country
  2. 9.1.1 Asia-Pacific Poliovirus Vaccine Inactivated Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Poliovirus Vaccine Inactivated Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Poliovirus Vaccine Inactivated Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Country
  6. 9.2.1 Asia-Pacific Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Poliovirus Vaccine Inactivated Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Poliovirus Vaccine Inactivated Sales by Country
  2. 10.1.1 South America Poliovirus Vaccine Inactivated Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Poliovirus Vaccine Inactivated Sales by Country (2021-2026)
  4. 10.1.3 South America Poliovirus Vaccine Inactivated Sales Forecast by Country (2027-2032)
  5. 10.2 South America Poliovirus Vaccine Inactivated Market Size by Country
  6. 10.2.1 South America Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Poliovirus Vaccine Inactivated Market Size by Country (2021-2026)
  8. 10.2.3 South America Poliovirus Vaccine Inactivated Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Poliovirus Vaccine Inactivated Sales by Country
  2. 11.1.1 Middle East and Africa Poliovirus Vaccine Inactivated Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Poliovirus Vaccine Inactivated Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Poliovirus Vaccine Inactivated Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Country
  6. 11.2.1 Middle East and Africa Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Poliovirus Vaccine Inactivated Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Poliovirus Vaccine Inactivated Value Chain Analysis
  2. 12.1.1 Poliovirus Vaccine Inactivated Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Poliovirus Vaccine Inactivated Production Mode & Process
  7. 12.2 Poliovirus Vaccine Inactivated Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Poliovirus Vaccine Inactivated Distributors
  10. 12.2.3 Poliovirus Vaccine Inactivated Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst